3.595
-0.105 (-2.84%)
-0.105 (-2.84%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.105 | -2.84% | 3.595 | 15:51:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.62 | 3.54 | 3.72 | 3.70 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.59 | 3.60 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,615 | 1,631,857 | $ 3.63 | $ 5,930,639 | 1,997,019 | 2.55 - 5.2997 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:52:05 | 100 | $ 3.595 | USD |
Catalyst Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 372.62M | 103.65M | 96.38M | $ 102.31M | $ 73.82M | 0.29 | 5.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.58 | 3.80 | 3.52 | 3.67 | 1,514,589 | 0.015 | 0.42% |
| 1 Month | 3.37 | 3.80 | 3.30 | 3.54 | 1,669,933 | 0.225 | 6.68% |
| 3 Months | 3.12 | 3.99 | 3.10 | 3.51 | 1,767,209 | 0.475 | 15.22% |
| 6 Months | 4.73 | 4.95 | 2.875 | 3.47 | 1,805,195 | -1.14 | -24.0% |
| 1 Year | 3.97 | 5.2997 | 2.55 | 3.90 | 1,844,741 | -0.375 | -9.45% |
| 3 Years | 3.59 | 7.67 | 1.85 | 3.96 | 1,684,662 | 0.005 | 0.14% |
| 5 Years | 2.02 | 7.67 | 0.51 | 3.40 | 1,383,349 | 1.58 | 77.97% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. |
